Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to StavudineDaniel Podzamczer, Luis del Río, Jordí Niubó et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 137
All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Ángela Gil‐Martin et al.|Hepatology|2018Cited by 79
Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimenJade Ghosn, Jean-François Delfraissy, Giampiero Carosi et al.|Antiviral Therapy|2010Cited by 39
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, José Luís Calleja et al.|Open Forum Infectious Diseases|2019Cited by 4